Search for: "Long v. U.s.*" Results 261 - 280 of 6,451
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Sep 2023, 8:09 am by Phil Dixon
This is particularly true as long as the qualified-immunity doctrine exists. [read post]
19 Sep 2023, 3:34 am by Kurt R. Karst
  Further, FDA has not opined on whether REMS patents can be listed in the Orange Book (though the FTC did not mince words in saying that such listings were anticompetitive in the Jazz v. [read post]
18 Sep 2023, 2:44 pm by Dennis Crouch
Leading Eligibility Case: In next week’s long conference (Sept 26), the court will consider what I see as the current leading case of CareDx Inc. v. [read post]
17 Sep 2023, 6:36 pm by Dennis Crouch
  And, it is that marketplace meaning that likely serves as the true basis of the long running lawsuit. [read post]
6 Sep 2023, 9:01 pm by renholding
When it approved the CAT, the Commission stated that plan participants could “recoup their regulatory costs . . . through the collection of fees from their members, as long as such fees are reasonable, equitably allocated, and not unfairly discriminatory. [read post]
27 Aug 2023, 3:56 pm by Andrew Warren
On August 14, 2023, a Fulton County, Georgia grand jury returned a 41-count indictment against former President Donald Trump and eighteen other individuals for a conspiracy to overturn the legitimate 2020 presidential election results in that state. [read post]